20043572

Source:http://linkedlifedata.com/resource/pubmed/id/20043572

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0013227, umls-concept:C0014442, umls-concept:C0019046, umls-concept:C0030705, umls-concept:C0039730, umls-concept:C0207509, umls-concept:C0449438, umls-concept:C1521725
pubmed:issue	12
pubmed:dateCreated	2010-1-1
pubmed:abstractText	To evaluate the drug metabolizing enzyme CYP1A2 activity in pediatric hemoglobin E-beta-thalassemia patients, since CYP1A2 is responsible for the metabolism of a number of drugs. Alteration of its activity may have clinical consequences.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/7507216
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/1,7-dimethylxanthine, http://linkedlifedata.com/resource/pubmed/chemical/CYP1A2 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Caffeine, http://linkedlifedata.com/resource/pubmed/chemical/Cytochrome P-450 CYP1A2, http://linkedlifedata.com/resource/pubmed/chemical/Ferritins, http://linkedlifedata.com/resource/pubmed/chemical/Glutathione, http://linkedlifedata.com/resource/pubmed/chemical/Hemoglobin E, http://linkedlifedata.com/resource/pubmed/chemical/Lipid Peroxides, http://linkedlifedata.com/resource/pubmed/chemical/Theophylline, http://linkedlifedata.com/resource/pubmed/chemical/Transaminases
pubmed:status	MEDLINE
pubmed:month	Dec
pubmed:issn	0125-2208
pubmed:author	pubmed-author:JetsrisuparbAruneeA, pubmed-author:KukongviriyapanUpaU, pubmed-author:KukongviriyapanVeerapolV, pubmed-author:SenggunpraiLaddawanL
pubmed:issnType	Print
pubmed:volume	92
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1675-80
pubmed:meshHeading	pubmed-meshheading:20043572-Caffeine, pubmed-meshheading:20043572-Case-Control Studies, pubmed-meshheading:20043572-Child, pubmed-meshheading:20043572-Confidence Intervals, pubmed-meshheading:20043572-Cytochrome P-450 CYP1A2, pubmed-meshheading:20043572-Female, pubmed-meshheading:20043572-Ferritins, pubmed-meshheading:20043572-Glutathione, pubmed-meshheading:20043572-Hemoglobin E, pubmed-meshheading:20043572-Humans, pubmed-meshheading:20043572-Lipid Peroxides, pubmed-meshheading:20043572-Liver, pubmed-meshheading:20043572-Male, pubmed-meshheading:20043572-Multivariate Analysis, pubmed-meshheading:20043572-Oxidative Stress, pubmed-meshheading:20043572-Sex Factors, pubmed-meshheading:20043572-Thailand, pubmed-meshheading:20043572-Theophylline, pubmed-meshheading:20043572-Transaminases, pubmed-meshheading:20043572-beta-Thalassemia
pubmed:year	2009
pubmed:articleTitle	Drug metabolizing enzyme CYP1A2 status in pediatric patients with hemoglobin E-beta thalassemia.
pubmed:affiliation	Department of Pharmacology, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand.
pubmed:publicationType	Journal Article, Research Support, Non-U.S. Gov't